Stikeman Elliott LLP and Latham & Watkins LLP acted as legal advisors to Freight Farms, and Borden Ladner Gervais LLP and Dorsey & Whitney LLP acted...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Divert, Inc. on the deal. Divert Inc., an impact technology company on a mission to Protect the Value of Food, on Sept....
You must be a Standard 1 Year member to access this content.
Latham and Watkins advised Transcend on the financing. Transcend Software Inc. announced it has closed on its Series B financing round with participation from Autodesk, Inc., a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Divert in the offering. Divert Dev Co I LLC, a wholly owned subsidiary of Divert, Inc., announced it has issued through the...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP represented Enbridge Inc., and Latham & Watkins LLP advised Divert. Enbridge Inc. (Enbridge or the Company) (TSX: ENB) (NYSE: ENB) announced its acquisition of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Syzygy Plasmonics in the transaction. Syzygy Plasmonics, a deep-decarbonization company that is electrifying chemical manufacturing, has announced a US$76 million Series...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented VillageMD in the transaction, Cleary Gottlieb and McDermott Will & Emery represented Summit Health-CityMD, while Wachtell, Lipton, Rosen & Katz served as legal...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented A24 in the transaction. A24, the entertainment company behind hits such as Moonlight and Euphoria, has received an equity investment of US$225...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Innocoll Biotherapeutics in the transaction. Innocoll Biotherapeutics plc, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, has announced the successful...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Interline Therapeutics on the deal. Interline Therapeutics, a data science and healthcare company, announced its $92 million Series...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Corvus Insurance on the deal. Corvus Insurance, the leading provider of smart commercial insurance products powered by...
You must be a Standard 1 Year member to access this content.
